CDEK
by
Data4ThePeople
Drugs
Organizations
Indications
Mechanisms
Trials
FDA Approvals
About
Sign in
Sign up
Drugs
Organizations
Indications
Mechanisms
Trials
FDA Approvals
About
← All organizations
Royalty
For profit
Phase 1
Phase 2
Phase 3
Phase 4
Timeline
Org Milestones
All Trials
Drug Relationships
1990s
Jan 1, 1996
Royalty
— Founded
2010s
Jan 6, 2011
Cypress Bioscience, Inc.
— Acquired
Drugs by trial phase
(1 distinct, 6 trials)
Phase 4
(0 own, 1 via acquisition)
milnacipran
Subsidiaries
(1 direct, 3 total across the full acquisition tree)
Cypress Bioscience, Inc.
Cellatope
L2
Proprius Pharmaceuticals
L2
Details
Founded
New York, NY, US
Jan 1, 1996